Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | IL-9 | 597.0 | 65 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-9 | 561.0 | 85 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-9 | 645.0 | 68 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-9 | 517.0 | 59 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | IL-9 | 653.0 | 69 | |
N2586 | IL-17A | 100 | ng/mL | 3 | IL-9 | 366.0 | 77 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | IL-9 | 403.0 | 91 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-9 | 242.0 | 80 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-9 | 440.0 | 73 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-9 | 339.0 | 77 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | IL-9 | 420.0 | 50 | |
RA2159 | IL-6 | 100 | ug/mL | 3 | IL-9 | 63.5 | 70 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | IL-9 | 57.0 | 83 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-9 | 62.5 | 78 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-9 | 65.0 | 81 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-9 | 71.0 | 73 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | IL-9 | 64.5 | 88 | |
RA2159 | Sigma A6730 | 3.0 | uM | 3 | IL-9 | 62.0 | 83 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | IL-9 | 72.0 | 96 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | IL-9 | 73.0 | 76 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-9 | 58.0 | 68 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-9 | 62.0 | 60 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-9 | 73.0 | 91 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | IL-9 | 82.0 | 53 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | IL-9 | 79.0 | 88 |